Gene · 3055
Papers2,931
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,931
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The mechanism study of Miao medicine Tongfengting decoction in the treatment of gout based on network pharmacology and molecular docking. | Medicine (Baltimore) | 2022 | 36595750 | PubTator, text mining | PubMed |
| Exosomes in pathogenesis, diagnosis, and therapy of ischemic stroke. | Front Bioeng Biotechnol | 2022 | 36588958 | PubTator, text mining | PubMed |
| SRC kinase-mediated signaling pathways and targeted therapies in breast cancer. | Breast Cancer Res | 2022 | 36581908 | PubTator, text mining | PubMed |
| Apoptosis regulation by the tyrosine-protein kinase CSK. | Front Cell Dev Biol | 2022 | 36578781 | PubTator, text mining | PubMed |
| Bioinformatic analysis and preliminary validation of potential therapeutic targets for COVID-19 infection in asthma patients. | Cell Commun Signal | 2022 | 36575422 | PubTator, text mining | PubMed |
| Synchronous triple primary malignant tumours in the bladder, prostate, and lung harbouring TP53 and MEK1 mutations accompanied with severe cardiovascular diseases: A case report. | Open Med (Wars) | 2022 | 36568519 | PubTator, text mining | PubMed |
| Bioinformatics analysis identifies immune-related gene signatures and subtypes in diabetic nephropathy. | Front Endocrinol (Lausanne) | 2022 | 36568106 | PubTator, text mining | PubMed |
| Thousands of human non-AUG extended proteoforms lack evidence of evolutionary selection among mammals. | Nat Commun | 2022 | 36564405 | PubTator, text mining | PubMed |
| Ampelopsin targets in cellular processes of cancer: Recent trends and advances. | Toxicol Rep | 2022 | 36561961 | PubTator, text mining | PubMed |
| SH2 Domains: Folding, Binding and Therapeutical Approaches. | Int J Mol Sci | 2022 | 36555586 | PubTator, text mining | PubMed |
| Integrated Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unravels the Influences of SARS-CoV-2 Infections to Cancer Patients. | Int J Mol Sci | 2022 | 36555339 | PubTator, text mining | PubMed |
| Activated PyK2 and Its Associated Molecules Transduce Cellular Signaling from the Cancerous Milieu for Cancer Metastasis. | Int J Mol Sci | 2022 | 36555115 | PubTator, text mining | PubMed |
| Asperosaponin VI induces osteogenic differentiation of human umbilical cord mesenchymal stem cells via the estrogen signaling pathway. | Medicine (Baltimore) | 2022 | 36550906 | PubTator, text mining | PubMed |
| Hypoxia and Cellular Senescence, Emerging Toxic Mechanisms of Mycotoxins and Toxins: A New Understanding of the Negative Immune Regulations. | Toxins (Basel) | 2022 | 36548777 | PubTator, text mining | PubMed |
| A Phase I Study of the Non-Receptor Kinase Inhibitor Bosutinib in Combination with Pemetrexed in Patients with Selected Metastatic Solid Tumors. | Curr Oncol | 2022 | 36547158 | PubTator, text mining | PubMed |
| Identifying differentially expressed genes and miRNAs in Kawasaki disease by bioinformatics analysis. | Sci Rep | 2022 | 36536067 | PubTator, text mining | PubMed |
| Construction and validation of a robust prognostic model based on immune features in sepsis. | Front Immunol | 2022 | 36532037 | PubTator, text mining | PubMed |
| Integrating cell interaction with transcription factors to obtain a robust gene panel for prognostic prediction and therapies in cholangiocarcinoma. | Front Genet | 2022 | 36531216 | PubTator, text mining | PubMed |
| Therapeutic targets and signaling mechanisms of dasatinib activity against radiation skin ulcer. | Front Public Health | 2022 | 36530656 | PubTator, text mining | PubMed |
| Vector design for enhancing expression level and assembly of knob-into-hole based FabscFv-Fc bispecific antibodies in CHO cells. | Antib Ther | 2022 | 36518226 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3055/papers?page=19